Tripti Gaur

Senior Director, Preclinical & Translational Sciences at Mustang Bio

Tripti Gaur has a diverse work experience in the field of preclinical and translational sciences. Tripti is currently working as the Senior Director of Preclinical & Translational Sciences at Mustang Bio, a position they have held since April 2022. Prior to this, they worked as the Director of Preclinical & Translational Sciences at the same company from September 2020 to March 2022.

Before joining Mustang Bio, Tripti held positions at CRISPR Therapeutics as an Associate Director of Clinical Biomarkers and Exploratory Research from September 2019 to September 2020, and at Takeda as an Associate Director of Quantitative Translational Sciences from January 2019 to September 2019 (via acquisition of Shire).

Their experience also includes roles at Shire, where they worked as an Associate Director of Bioanalytical and Biomarker Development from July 2018 to January 2019 (via acquisition of Dyax), and as a Senior Scientist from January 2016 to July 2018 (via acquisition of Dyax). Tripti started their professional career at Dyax Corp. as a Senior Scientist in Pharmacology and Preclinical Development from November 2015 to January 2016.

Prior to their industry experience, Tripti worked at Cambridge Biomedical Inc. as a Senior Research Scientist from August 2014 to October 2015. Their earliest industry experience was at Olympus Biotech Corporation, where they worked as a Senior Scientist in Research & Development/Preclinical. Their role at Olympus involved various responsibilities such as establishing cell culture facilities and molecular biology labs, conducting early discovery research, preclinical drug development and validation of assays, and designing and executing preclinical pharmacology studies. Tripti worked at Olympus from May 2012 to June 2014.

Tripti's academic background includes positions at UMass Medical School, where they worked as an Assistant Professor from January 2010 to April 2012, as an Instructor from September 2006 to December 2009, and as a Postdoctoral Fellow from September 2002 to August 2006.

Tripti Gaur holds a Doctor of Philosophy (PhD) in Plant Molecular Biology from Delhi University, which they obtained between 1997 and 2002. Tripti also holds a Master of Science (MS) in Biochemistry from G. B. Pant University Of Agriculture & Technology, and a Bachelor of Science (BS) in Biology from Kanpur University, India.

Links

Previous companies

CRISPR Therapeutics logo
UMass Chan Medical School logo
Takeda Pharmaceutical logo

Org chart

Timeline

  • Senior Director, Preclinical & Translational Sciences

    April, 2022 - present

  • Director, Preclinical & Translational Sciences

    September, 2020

View in org chart